Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Lanzenberger

Showing results (1-10 of 283) with videos related to

Pageof 29
Sort By:
The Lancet. Psychiatry|September 12, 2015
Imaging brain circuits in anxiety disordersSiegfried Kasper, Gregor Gryglewski, Rupert Lanzenberger
Amino Acids|September 28, 2011
Serotonin and molecular neuroimaging in humans using PETAnne Saulin, Markus Savli, Rupert Lanzenberger
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 15, 2012
Testosterone in the brain: neuroimaging findings and the potential role for neuropsychopharmacologyPeter Höfer, Rupert Lanzenberger, Siegfried Kasper
JAMA Psychiatry|July 13, 2017
Ketamine for the Treatment of DepressionChristoph Kraus, Rupert Lanzenberger, Siegfried Kasper
Biological Psychiatry|May 9, 2009
The serotonin-1A receptor in anxiety disordersElena Akimova, Rupert Lanzenberger, Siegfried Kasper
The International Journal of Neuropsychopharmacology|December 14, 2018
Making Sense of ConnectivityAndreas Hahn, Rupert Lanzenberger, Siegfried Kasper
Chemical Senses|October 23, 2019
Probing the Impact of Gender-Affirming Hormone Treatment on Odor PerceptionGeorg S Kranz, Ulrike Kaufmann, Rupert Lanzenberger
Biological Psychiatry|July 26, 2014
Testosterone, neural circuits, and male depressionSiegfried Kasper, Georg S Kranz, Rupert Lanzenberger
Handbook of Clinical Neurology|October 3, 2020
PrefaceRupert Lanzenberger, Georg S Kranz, Ivanka Savic
The International Journal of Neuropsychopharmacology|May 6, 2015
Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled TrialsMarkus Dold, Martin Aigner, Rupert Lanzenberger, et al.
Pageof 29

Showing results (1-10 of 283) with videos related to

Sort By:
Pageof 29
The Lancet. Psychiatry|September 12, 2015
Imaging brain circuits in anxiety disordersSiegfried Kasper, Gregor Gryglewski, Rupert Lanzenberger
Amino Acids|September 28, 2011
Serotonin and molecular neuroimaging in humans using PETAnne Saulin, Markus Savli, Rupert Lanzenberger
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 15, 2012
Testosterone in the brain: neuroimaging findings and the potential role for neuropsychopharmacologyPeter Höfer, Rupert Lanzenberger, Siegfried Kasper
JAMA Psychiatry|July 13, 2017
Ketamine for the Treatment of DepressionChristoph Kraus, Rupert Lanzenberger, Siegfried Kasper
Biological Psychiatry|May 9, 2009
The serotonin-1A receptor in anxiety disordersElena Akimova, Rupert Lanzenberger, Siegfried Kasper
The International Journal of Neuropsychopharmacology|December 14, 2018
Making Sense of ConnectivityAndreas Hahn, Rupert Lanzenberger, Siegfried Kasper
Chemical Senses|October 23, 2019
Probing the Impact of Gender-Affirming Hormone Treatment on Odor PerceptionGeorg S Kranz, Ulrike Kaufmann, Rupert Lanzenberger
Biological Psychiatry|July 26, 2014
Testosterone, neural circuits, and male depressionSiegfried Kasper, Georg S Kranz, Rupert Lanzenberger
Handbook of Clinical Neurology|October 3, 2020
PrefaceRupert Lanzenberger, Georg S Kranz, Ivanka Savic
The International Journal of Neuropsychopharmacology|May 6, 2015
Antipsychotic Augmentation of Serotonin Reuptake Inhibitors in Treatment-Resistant Obsessive-Compulsive Disorder: An Update Meta-Analysis of Double-Blind, Randomized, Placebo-Controlled TrialsMarkus Dold, Martin Aigner, Rupert Lanzenberger, et al.
Pageof 29